Strategic Partnerships Leverage Alzamend Neuro’s ongoing Phase II trials in collaboration with Massachusetts General Hospital and their engagement with Mass General Brigham to propose joint research initiatives, co-development opportunities, or expanded access studies with academic medical centers and large health systems.

Clinical Trial Expansion Target their AL001 program across bipolar disorder, Alzheimer's disease, MDD, and PTSD for trial site expansion, imaging analytics partnerships with AI platforms like QMENTA, and patient recruitment services to accelerate Phase II/III timelines.

BIotech Stakeholder Fit Position mid-market biopharma services to support a small, agile company with a revenue range of under ten million by offering cost-effective clinical operations, regulatory support, and CRO partnerships tailored to a lean sponsor model.

Imaging and Analytics Capitalize on their collaboration with QMENTA for AI-driven imaging by offering advanced imaging analytics, biomarker validation, and data management solutions to enhance trial endpoints and patient stratification.

Investor and Outreach Support their investor relations and visibility efforts by providing selective investor-day materials, scientific communications, and event sponsorships aligned with their scheduled appearances at conferences and summits to attract potential funding and partnerships.